Abstract
Background: Weeks after issuing social distancing orders, all U.S. states and the District of Columbia at least partially relaxed these measures. Critical unanswered questions remain about the timing of relaxation, and if and how unregulated social distancing measures can be sustained while effectively maintaining epidemic control. Methods: We identified all statewide social distancing measures that were implemented and/or relaxed in the U.S. between March 10-July 15, 2020, triangulating data from state government and third-party sources. Using segmented linear regression, we evaluated the extent to which social distancing measure relaxation affected epidemic control, as indicated by the time-varying, state-specific effective reproduction number (R[t]). Results: In the eight weeks prior to relaxation, mean R[t] declined by 0.012 units per day (95% CI, -0.013 to -0.012), and 46/51 jurisdictions achieved R[t] < 1.0 by the date of relaxation. After relaxation of social distancing, R[t] reversed course and began increasing by 0.007 units per day (95% CI, 0.006-0.007), reaching a mean R[t] of 1.16 eight weeks later, with only 9/51 jurisdictions maintaining R[t] <1.0. Indicators often used to motivate relaxation at the time of relaxation (e.g. test positivity rate <5%) predicted greater post-relaxation epidemic growth. Conclusions: We detected an immediate and significant reversal in epidemic growth gains after relaxation of social distancing measures across the U.S. These results illustrate the potential pitfalls of premature relaxation of social distancing measures in the U.S.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Sir Henry Dale Fellowship, Wellcome Trust (UK); Sullivan Family Foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This ecological analysis was based on publicly available data and was exempt from ethical review.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Augmented with data collected through July 15, 2020. Seven sensitivity analyses added.
Data Availability
The data on social distancing policies are contained within the Supplementary Appendix Table. The data on COVID-19 cases and deaths are publicly available from https://github.com/nytimes/covid-19-data.
